← Back to overview

A Agilent Technologies, Inc.

Life Sciences Tools & Services · $138.57 -0.84%
EN PL
Price Alert:

Compare

Shows % change over the period so different-priced stocks can be compared fairly.

Technical Indicators

RSI (14)
63.9
Relative Strength Index (RSI): measures how fast and how much the price has moved recently, on a 0-100 scale. Above 70 is often called "overbought" (may be due for a pause or pullback); below 30 is "oversold" (may be due for a bounce). It is not a guarantee either way.
SMA 20 / 50 / 200
133.39 / 128.46 / 131.02
Moving Averages (SMA): the average closing price over the last N days, smoothing out day-to-day noise. When price trades above its moving averages, and shorter averages are above longer ones, it is generally read as a healthier trend.
MACD / Signal
1.68 / 1.60
MACD: compares two moving averages (12-day and 26-day) to gauge momentum. When the MACD line crosses above its signal line, momentum is turning up; crossing below suggests momentum turning down.

Fundamentals

P/E
27.9
Price-to-Earnings ratio: how many dollars investors pay for $1 of the company's annual profit. Higher usually means the market expects faster growth (or the stock is expensive); lower can mean it's cheap — or that growth is expected to slow.
Market Cap
39.14B
Market Capitalization: the total value of all the company's shares — share price × number of shares. A rough measure of company size.
Div Yield
0.74%
Dividend Yield: the annual cash dividend paid to shareholders, as a percentage of the current share price.
52-Week Range
108.35 – 160.27
52-Week Range: the lowest and highest price the stock has traded at over the last year. Where the price sits in this range hints at recent strength or weakness.

Trend Analysis

Agilent Technologies, Inc. is trading at $138.57, -0.84% versus the previous close. The price sits roughly in the middle of its 52-week range.
RSI is in a neutral range — no strong overbought/oversold signal.
The 50-day average is below the 200-day average ("death cross" territory) — a commonly watched bearish signal.
MACD is above its signal line — momentum currently leans positive.
Combine this reading with the fundamentals below before forming a view — no single indicator is a guarantee of what happens next.

Latest News

Is Agilent Technologies (A) Undervalued Following Its FDA Approval For OPDIVO Companion Diagnostics?
Simply Wall St. · 2026-07-25 21:16
Why Agilent Technologies (A) Is Up 5.4% After New FDA Nod For OPDIVO Cancer Test
Simply Wall St. · 2026-07-25 15:12
What to Expect From Agilent Technologies' Q3 2026 Earnings Report
Barchart · 2026-07-24 15:39
Can GE HealthCare Sustain Growth in Q2 Amid Persistent Cost Headwinds?
Zacks · 2026-07-24 15:24
Will Baxter's Q2 Results Continue to Reflect Operational Headwinds?
Zacks · 2026-07-24 15:21
1 Healthcare Stock to Research Further and 2 We Avoid
StockStory · 2026-07-24 12:49
Reading Between The Lines Of DHR's Latest Call
Trefis · 2026-07-24 12:23
In Vitro Toxicology Testing Market to Exceed $20.97 Billion by 2031 as Non-Animal Testing & AI Adoption Accelerate - Analysis by Product, Toxicity Endpoints & Type, Technology, Method, Service, Region
GlobeNewswire · 2026-07-23 14:09
Educational information only. Nothing here is investment advice — always do your own research and consider talking to a licensed financial advisor before buying or selling.
Data: Yahoo Finance, refreshed periodically and cached locally.